Róbert Hatala
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Atrial Fibrillation Management and Outcomes
- Cardiac pacing and defibrillation studies
- ECG Monitoring and Analysis
- Cardiac Imaging and Diagnostics
- Cardiovascular Syncope and Autonomic Disorders
- Blood Pressure and Hypertension Studies
- Pharmaceutical industry and healthcare
- Heart Rate Variability and Autonomic Control
- Meta-analysis and systematic reviews
- Cardiac, Anesthesia and Surgical Outcomes
- scientometrics and bibliometrics research
- Cardiomyopathy and Myosin Studies
- Cardiovascular Effects of Exercise
- Antiplatelet Therapy and Cardiovascular Diseases
- COVID-19 Clinical Research Studies
- Congenital Heart Disease Studies
- Cardiovascular Function and Risk Factors
- COVID-19 and Mental Health
- Health and Medical Research Impacts
- Cardiac Health and Mental Health
- Health Systems, Economic Evaluations, Quality of Life
- Apelin-related biomedical research
- Medical Imaging Techniques and Applications
National Institute of Cardiovascular Diseases
2016-2025
Slovak Medical University
2015-2024
Comenius University Bratislava
1992-2024
National Institute of Cardiovascular Diseases
2024
University clinical center of Republika Srpska
2021
Palacký University Olomouc
2020
Detská Fakultná Nemocnica s Poliklinikou
1990-2020
Hong Kong College of Technology
2020
Castle Peak Hospital
2020
Hospital Universitario de La Princesa
2019
Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This can be modified lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve stabilization regression. The have long, stable periods but also become unstable at any time, typically due an acute atherothrombotic event caused rupture erosion. However, chronic, most often...
2012 focused update of the ESC Guidelines for management atrial fibrillation : an 2010 fibrillation: developed with special contribution European Heart Rhythm Association
The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical...
The ESC Guidelines represent the views of and were arrived at after careful consideration available evidence
Vedran Velagic (Croatia), Sami Viskin (Israel)
Implantable cardioverter–defibrillator (ICD) therapy has been shown to improve survival in patients with various heart conditions who are at high risk for ventricular arrhythmias. Whether benefit occurs early after myocardial infarction is unknown.
2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and Prevention Sudden Cardiac Death
Abstract Aims A majority of acute coronary syndromes (ACS) present without typical ST elevation. One-third non–ST-elevation myocardial infarction (NSTEMI) patients have an acutely occluded culprit artery [occlusion (OMI)], leading to poor outcomes due delayed identification and invasive management. In this study, we sought develop a versatile artificial intelligence (AI) model detecting OMI on single-standard 12-lead electrocardiograms (ECGs) compare its performance with existing...
De novo implanted cardiac resynchronization therapy with defibrillator (CRT-D) reduces the risk of morbidity and mortality in patients left bundle branch block, heart failure reduced ejection fraction (HFrEF). However, among HFrEF right ventricular pacing (RVP), efficacy CRT-D upgrade is uncertain.
The EUropean Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter-Defibrillators (EU-CERT-ICD), a prospective investigator-initiated, controlled cohort study, was conducted in 44 centres and 15 European countries. It aimed assess current clinical effectiveness primary prevention ICD therapy.We recruited 2327 patients with ischaemic cardiomyopathy (ICM) or dilated (DCM) guideline indications for prophylactic implantation. endpoint all-cause...
Abstract
The indication to treat paroxysmal atrial fibrillation (PAF) is controversial. Suppression of Paroxysmal Atrial Tachyarrhythmias (SOPAT) trial was designed answer the following questions: (1) What average rate spontaneous events symptomatic PAF with and without anti-arrhythmic medication? (2) what prevalence severe side-effects? (3) fixed combination Quinidine+Verapamil inferior efficacy sotalol or not? Within 60 months 172 centres in Germany, Poland, Slovak Republic prospectively enrolled...
Implantable cardiac defibrillator SCD Sudden death SSRI Selective serotonin receptor inhibitor VF Ventricular fibrillation VT tachycardia PreambleThis expert consensus aims to provide guidance for the management of patients receiving one or multiple shocks from an ICD.The document expresses view a multidisciplinary group experts in fields general adult cardiology, ICD treatment, invasive electrophysiology, and psychosomatic medicine.A variety clinical settings, including emergency medicine,...
[2015 ESC Guidelines for the management of patients with ventricular arrhythmias and prevention sudden cardiac Death. The Task Force Management Patients Ventricular Arrhythmias Prevention Sudden Cardiac Death European Society Cardiology].
The electrocardiogram (ECG) is one of the most accessible and comprehensive diagnostic tools used to assess cardiac patients at first point contact. Despite advances in computerized interpretation (CIE), its accuracy remains inferior physicians. This study evaluated performance an artificial intelligence (AI)-powered ECG system compared current state-of-the-art CIE. An AI-powered consisting 6 deep neural networks (DNN) was trained on standard 12‑lead ECGs detect 20 essential patterns...
Right ventricular pacing (VP) has been hypothesized to increase the risk in heart failure (HF) and atrial fibrillation (AF). The ANSWER study evaluated, whether an AAI-DDD changeover mode minimize VP (SafeR) improves outcome compared with DDD a general dual-chamber pacemaker population.ANSWER was randomized controlled multicentre trial assessing SafeR vs. standard sinus node disease (SND) or AV block (AVB) patients. After 1-month run-in period, they were (1 : 1) followed for 3 years....
Clinicians accept that there are many unknowns when we make diagnostic and therapeutic decisions. Acceptance of uncertainty is essential for the pursuit profession: bedside decisions must often be made on basis incomplete evidence. Over years, physicians sometimes even do not realize anymore which fundamental gaps in our knowledge are. As clinical scientists, however, have to halt consider what know yet, how can move forward addressing those unknowns. The European Heart Rhythm Association...
Abstract Background: Patients with atrial fibrillation (AF) have a higher risk of fatal complications (e.g., stroke). This investigation was performed as an observational retrospective cohort study includes 137 patients (age 61 ± 15; 34.3% women) primary diagnosis AF (paroxysmal, persistent, and permanent). Methods: We collected information about the drug therapy, comorbidities survival determined their congestive heart failure, hypertension, age, diabetes mellitus, prior stroke or TIA...